Catalys-Pacific

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MLYS",
  "PHAT"
]

13F-HR • 2025-03-31

Data Enrichment

100% identified

2 identified0 unidentified

Holdings

Manager:

2 positions • $148.7M total value

Manager:

Search and click to pin securities to the top

Sort by:

Mineralys Therapeutics, Inc.

Shares:8.6M

Value:$141.4M

% of Portfolio:95.1% ($141.4M/$148.7M)

Phathom Pharmaceuticals, Inc.

Shares:1.2M

Value:$7.3M

% of Portfolio:4.9% ($7.3M/$148.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Mineralys Therapeutics, Inc.(MLYScusip603170101)	8.6M	QoQ 0.00% (+0) YoY -5.98% (-550.0K)	All Managers (Combined)	$141.4M	95.1% ($141.4M/$148.7M)	QoQ +32.86% (+$35.0M) YoY +19.11% (-$22.7M)
Phathom Pharmaceuticals, Inc.(PHATcusip71722W107)	1.2M	QoQ 0.00% (-0) YoY +61.65% (-445.2K)	All Managers (Combined)	$7.3M	4.9% ($7.3M/$148.7M)	QoQ -22.78% (-$2.2M) YoY -4.55% (-$349.4K)